Yu Lan, Zhang Xiao-Tao, Guan Shang-Hui, Cheng Yu-Feng, Li Lin-Xi
School of Medicine, Shandong University, Jinan 250012, China.
Cancer Prevention Center, Qingdao Central (Cancer) Hospital, The Second Affiliated Hospital of University Qingdao, Qingdao 266042, China.
Open Med (Wars). 2020 Mar 8;15:152-159. doi: 10.1515/med-2020-0023. eCollection 2020.
There is a controversial relationship between the negative lymph nodes (NLNs) and survival in patients with esophageal squamous cell carcinoma (ESCC). This study investigates the implications of total number of NLNs on thoracic ESCC patient prognosis.
579 thoracic ESCC patients were categorized into four groups (0-9, 10-14, 15-19 and ≥20 NLNs). Univariate analysis was done by the log-rank tests while multivariate analysis was undertaken using Cox regression models. Survival analysis was determined employing the Kaplan-Meier method.
When the numbers of NLNs were 9 or less, 10 to 14, 15 to 19 and 20 or more, patients of 3-year survival rates were 21.7%, 40.0%, 61.2% and 77.5%, respectively (<0.001). In the node-negative and node-positive subgroups, 3-year survival rates were 34.9% and 14.3%, 50.9% and 19.3%, 65.6% and 51.8%, 81.4% and 68.9% respectively (<0.001). Gender, tumor length, tumor differentiation, T and N stage as well as the total NLNs were found to be significantly linked to survival rates. Multivariate analysis showed tumor length, T stage, N stage and total NLNs were independent prognostic factors for ESCC patients.
NLNs numbers is a significant independent prognostic indicator for thoracic ESCC patients' survival after curative esophagectomy.
食管鳞状细胞癌(ESCC)患者中,阴性淋巴结(NLNs)与生存率之间的关系存在争议。本研究探讨NLNs总数对胸段ESCC患者预后的影响。
579例胸段ESCC患者被分为四组(0 - 9个、10 - 14个、15 - 19个和≥20个NLNs)。采用对数秩检验进行单因素分析,使用Cox回归模型进行多因素分析。采用Kaplan-Meier法进行生存分析。
当NLNs数量为9个及以下、10至14个、15至19个和20个及以上时,患者的3年生存率分别为21.7%、40.0%、61.2%和77.5%(<0.001)。在淋巴结阴性和阳性亚组中,3年生存率分别为34.9%和14.3%、50.9%和19.3%、65.6%和51.8%、81.4%和68.9%(<0.001)。发现性别、肿瘤长度、肿瘤分化程度、T和N分期以及NLNs总数与生存率显著相关。多因素分析显示,肿瘤长度、T分期、N分期和NLNs总数是ESCC患者的独立预后因素。
NLNs数量是胸段ESCC患者根治性食管切除术后生存的重要独立预后指标。